Kvk Tech Company Profile
What is the competitive landscape for KVK TECH
KVK TECH has twelve approved drugs.
Drugs and US Patents for Kvk Tech
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kvk Tech Inc | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | TABLET;ORAL | 203436-001 | Mar 17, 2017 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Kvk Tech | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride | TABLET;ORAL | 090968-001 | Jul 20, 2010 | AA | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Kvk Tech | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 040712-002 | May 4, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

